Michael Thomas Heffernan

Insider Reports History

Location: C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Signature: /s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Thomas Heffernan:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
COLLEGIUM PHARMACEUTICAL, INC	Director	Common Stock	50.3K	$1.54M	$30.52	Feb 10, 2025	Direct
Akebia Therapeutics, Inc.	Director	Common Stock	48.6K	$59.4K	$1.22	Jun 2, 2021	Direct
enGene Holdings Inc.	Director	Stock Option (Right to Buy)	45K			Jul 8, 2025	Direct
Trevi Therapeutics, Inc.	Director	Nonstatutory Stock Option (right to buy)	45K			Jun 11, 2025	Direct
Biohaven Ltd.	Director	Stock Options (Right to buy)	31.7K			May 5, 2025	Direct
SYNLOGIC, INC.	Director	Stock Option (right to buy)	30K			Jun 22, 2023	Direct
Avalo Therapeutics, Inc.	Director	Stock Option (Right to Buy)	29.5K			Jun 17, 2025	Direct
Akebia Therapeutics, Inc.	Director	Stock Option (Right to buy)	20.1K			Jun 2, 2021	Direct
Biohaven Pharmaceutical Holding Co Ltd.	Director	Restricted Share Unit Award	0			Oct 3, 2022	Direct
Biohaven Pharmaceutical Holding Co Ltd.	Director	Stock Options (Right to Buy)	0			Oct 3, 2022	Direct

Previous1Next

Showing 1 to 10 of 10 entries

Insider Reports Filed by Michael Thomas Heffernan

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ENGN	enGene Holdings Inc.	Jul 8, 2025	1	$0	4	Jul 10, 2025	Director
ENGN	enGene Holdings Inc.	Jul 8, 2025	0	$0	3	Jul 8, 2025	Director
AVTX	Avalo Therapeutics, Inc.	Jun 17, 2025	1	$0	4	Jun 18, 2025	Director
TRVI	Trevi Therapeutics, Inc.	Jun 11, 2025	1	$0	4	Jun 13, 2025	Director
BHVN	Biohaven Ltd.	May 5, 2025	1	$0	4	May 7, 2025	Director
AVTX	Avalo Therapeutics, Inc.	Mar 25, 2025	1	$0	4	Mar 26, 2025	Director
AVTX	Avalo Therapeutics, Inc.	Mar 25, 2025	0	$0	3	Mar 26, 2025	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	Feb 10, 2025	1	$0	4	Feb 12, 2025	Director
TRVI	Trevi Therapeutics, Inc.	Jun 13, 2024	1	$0	4	Jun 14, 2024	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	May 16, 2024	1	$0	4	May 16, 2024	Director
BHVN	Biohaven Ltd.	Apr 30, 2024	1	$0	4	May 2, 2024	Director
TRVI	Trevi Therapeutics, Inc.	Jun 28, 2023	1	$0	4	Jun 30, 2023	Director
SYBX	SYNLOGIC, INC.	Jun 22, 2023	1	$0	4	Jun 26, 2023	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	May 18, 2023	1	$0	4	May 19, 2023	Director
BHVN	Biohaven Ltd.	May 2, 2023	1	$0	4	May 4, 2023	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	Dec 22, 2022	12	-$186K	4	Dec 27, 2022	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	Dec 19, 2022	9	-$583K	4	Dec 21, 2022	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	Dec 12, 2022	14	-$1.33M	4	Dec 14, 2022	Director
BHVN	Biohaven Ltd.	Oct 3, 2022	1	-$72.7K	4/A	Oct 12, 2022	Director
BHVN	Biohaven Pharmaceutical Holding Co Ltd.	Oct 3, 2022	4	$0	4	Oct 3, 2022	Director
BHVN	Biohaven Ltd.	Sep 28, 2022	0	$0	3	Sep 30, 2022	Director
TRVI	Trevi Therapeutics, Inc.	Jun 23, 2022	1	$0	4/A	Jul 1, 2022	Director
SYBX	SYNLOGIC, INC.	Jun 9, 2022	1	$0	4	Jun 13, 2022	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	May 19, 2022	1	$0	4	May 23, 2022	Director
BHVN	Biohaven Pharmaceutical Holding Co Ltd.	Apr 28, 2022	1	$0	4	Apr 29, 2022	Director
BHVN	Biohaven Pharmaceutical Holding Co Ltd.	Dec 20, 2021	1	$0	4	Dec 22, 2021	Director
TRVI	Trevi Therapeutics, Inc.	Jun 16, 2021	1	$0	4	Jun 17, 2021	Director
SYBX	SYNLOGIC, INC.	Jun 10, 2021	1	$0	4	Jun 14, 2021	Director
AKBA	Akebia Therapeutics, Inc.	Jun 2, 2021	2	$0	4	Jun 3, 2021	Director
COLL	COLLEGIUM PHARMACEUTICAL, INC	May 20, 2021	1	$0	4	May 24, 2021	Director
BHVN	Biohaven Pharmaceutical Holding Co Ltd.	May 5, 2021	1	$0	4	May 7, 2021	Director